NICE INSIGHT REPORT

Gene Therapy:
2024 Market Insight, CDMO Pricing and Competitor Benchmarking

Coming October, 2024

2024 gene therapy CDMO pricing data and benchmarking report

Over 50 capability profiles of CDMOs specializing in gene therapy

Over 100 pages of gene therapy manufacturing market intelligence

Scientific analysis of gene therapy development and applications

Essential market insights for CDMOs, innovators and investors

Key market intelligence for innovators, CDMOs and investors in the gene therapy market.

Exclusive CDMO pricing data for benchmarking

Measure your business against your peers using our robust analysis of the gene therapy contract development and manufacturing market. Our pricing matrix comprises material cost, infrastructure and development process data from CDMOs all over the world so you can make informed decisions to best position your business.

Scientific analysis of gene therapies

Comprehensive overview of the gene therapy landscape in 2024, including information on AAV, Lentiviral and non-viral gene therapies. Discover the trends and technologies shaping gene therapy development and manufacturing with exclusive input from innovators, CDMO owners, PhDs and researchers across advanced therapeutics.

The Gene Therapy: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking provides

Competitive benchmarking data from gene therapy CDMOs all over the world

50+ company profiles of companies specializing in gene therapies

Scientific analysis of the gene therapy development and manufacturing process

Unique benefits and complexities of gene therapies in regards to accessibility, cost and applications

Investment outlook of the gene therapy market — analyzing economic and regulatory conditions

Innovations and breakthroughs that are powering gene therapy development and manufacturing